- Home
- / Premier Biomedical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Premier Biomedical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$1 M
2024-10-29
Revenue
$14.3 K
FY, 2019
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.8K | 39.8K | 14.3K | |||||
| Cost of goods sold | 25.4K | 113.7K | 12.9K | |||||
| Gross profit | 14.3K | (73.9K) | 1.4K | |||||
| Gross profit margin, % | 36.0% | -185.8% | 10.0% | |||||
| General and administrative expense | 35.9K | 3.0M | 223.4K | 133.3K | 191.4K | 196.7K | 189.3K | 200.6K |
| Operating expense total | 117.3K | 3.2M | 419.6K | 367.4K | 305.2K | 1.3M | 618.9K | 328.2K |
| EBIT | (1.7M) | (4.5M) | (1.4M) | (2.4M) | (637.9K) | (1.3M) | (692.8K) | (326.7K) |
| EBIT margin, % | -3244.0% | -1741.0% | -2287.9% | |||||
| Interest expense | 626.0 | 400.4K | 41.6K | 198.9K | 817.4K | 2.5M | 294.0K | |
| Pre tax profit | (1.7M) | |||||||
| Net Income | (1.7M) | (4.9M) | (1.4M) | (2.6M) | (1.8M) | (3.8M) | (398.9K) | (374.5K) |